Risk of Recurrent CeAD After Pregnancy
LONG-RECAP
Long-term Risk of Recurrent Cervical Artery Dissection After Pregnancy (LONG-RECAP Study)
1 other identifier
observational
1,000
9 countries
12
Brief Summary
Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 11, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedDecember 13, 2024
December 1, 2024
1.9 years
January 11, 2024
December 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with composite outcome measure - recurrent CeAD, ischemic stroke, hemorrhagic stroke and/or death
The composite outcome measure includes the following outcome measures during the follow-up: (i) occurence of recurrent cervical artery dissection (CeAD), (ii) occurrence of any ischemic stroke, (iii) occurrence of any hemorrhagic stroke, (iv) death.
From date of first CeAD until date of latest follow-up assessed up to 35 years
Secondary Outcomes (5)
Number of participants with recurrent cervical artery dissection
From date of first CeAD until date of latest follow-up assessed up to 35 years
Number of participants with new ischemic stroke
From date of first CeAD until date of latest follow-up assessed up to 35 years
Number of participants with new hemorrhagic stroke
From date of first CeAD until date of latest follow-up assessed up to 35 years
Number of participants with death
From date of first CeAD until date of latest follow-up assessed up to 35 years
Functional outcome as assessed by modified Rankin Scale (mRS)
At date of latest, individual follow-up assessed up to 35 years after first CeAD
Study Arms (2)
Women with pregnancy after index CeAD
Women who became pregnant at least once after first index CeAD
Women without pregnancy after index CeAD
Women who did not became pregnant after first index CeAD
Eligibility Criteria
Female patients aged ≥18 years with prior CeAD.
You may qualify if:
- female
- prior symptomatic cervical artery dissection (= index CeAD)
- at least one long-term follow-up visit (at least 6 months after the initial event)
- with information available on outcome events:
- recurrent dissection
- ischemic stroke
- hemorrhagic stroke
- functional outcome assessed by mRS score
- with data on pregnancy after the initial event
- at least 18 years old at the initial event
You may not qualify if:
- Male patients
- Age \<18 years
- No long-term follow-up available or long-term follow-up \< 6 months after initial event
- No data on pregnancy after initial event available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
University of Utah
Salt Lake City, Utah, 84112, United States
University of Virginia
Charlottesville, Virginia, 22908, United States
Stroke Unit Sanatorio Allende
Córdoba, X5000BFB, Argentina
Department of Neurology, Medical University of Innsbruck
Innsbruck, Tyrol, 6020, Austria
Helsinki University Central Hospital
Helsinki, Finland
Charité Universitätsmedizin, Centrum für Schlaganfallforschung
Berlin, 10117, Germany
Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern
Munich, 81377, Germany
Hadassah-Hebrew University Medical Center
Jerusalem, 91120, Israel
Neurology Clinic, University of Brescia
Brescia, Italy
Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez
Mexico City, 14269, Mexico
University Hospital Basel, Stroke Center
Basel, 4031, Switzerland
University Hospital Zurich, Stroke Center
Zurich, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan T Engelter, MD
University Hospital, Basel, Switzerland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2024
First Posted
February 14, 2024
Study Start
January 1, 2023
Primary Completion
December 1, 2024
Study Completion
July 1, 2025
Last Updated
December 13, 2024
Record last verified: 2024-12